Drug · DIN 02139618
LYPHOLYTE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since January 10, 2008; first marketed August 14, 1996.
- Drug Identification Number (DIN)
- 02139618
- Company (DIN owner)
- Pharmaceutical Partners Of Canada IncRichmond Hill, Ontario, Canada
- Schedule
- Ethical
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Combinations of electrolytes B05XA30
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SODIUM ACETATE | 2.7 G | 20 ML |
| POTASSIUM CHLORIDE | 2.5 G | 20 ML |
| SODIUM GLUCONATE | 1.1 G | 20 ML |
| MAGNESIUM ACETATE | 860 MG | 20 ML |
| POTASSIUM ACETATE | 690 MG | 20 ML |
| CALCIUM ACETATE | 440 MG | 20 ML |